{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:01:49Z","timestamp":1794063709021,"version":"4.8.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jmii.2024.11.003","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T04:08:54Z","timestamp":1731470934000},"page":"7-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Forty years of HIV infection and AIDS in Taiwan: Reflection on the past and looking toward the future"],"prefix":"10.1016","volume":"58","author":[{"given":"Sung-Hsi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0730-8935","authenticated-orcid":false,"given":"Hsun-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Wen-Wei Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1729-790X","authenticated-orcid":false,"given":"Po-Hsien","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Jhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement_2","key":"10.1016\/j.jmii.2024.11.003_bib1","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1093\/clinids\/17.Supplement_2.S337","article-title":"AIDS in the Republic of China, 1992","volume":"17","author":"Chuang","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib2","first-page":"200","article-title":"A case comparison of acquired immune deficiency syndrome (AIDS) in homosexual males with spindle-endothelial cell abnormalities and with recrudescent melioidosis","volume":"3","author":"Tanphaichitra","year":"1985","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jmii.2024.11.003_bib3","first-page":"25","article-title":"An autopsy-proved case of AIDS in Taiwan","volume":"5","author":"Lin","year":"1987","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2516.1995.tb00083.x","article-title":"A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates","volume":"1","author":"Shen","year":"1995","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib5","first-page":"51","article-title":"Transfusion-acquired AIDS in Taiwan","volume":"95","author":"Yao","year":"1996","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib6","first-page":"527","article-title":"Analysis of cost saving from nucleic acid amplification testing of all blood donations for viral infection in Taiwan","volume":"37","author":"Hsu","year":"2018","journal-title":"Taiwan J Public Health"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1089\/aid.2006.22.1055","article-title":"Molecular epidemiology of HIV type 1 subtypes in taiwan: outbreak of HIV type 1 CRF07BC infection in intravenous drug users","volume":"22","author":"Chang","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2013.83","article-title":"Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users","volume":"2","author":"Lin","year":"2013","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3201\/eid1204.050762","article-title":"HIV-1 CRF07_BC infections, injecting drug users, Taiwan","volume":"12","author":"Chen","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.qai.0000214818.80539.da","article-title":"An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan","volume":"42","author":"Lin","year":"2006","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1016\/j.jmii.2024.11.003_bib11","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1086\/513437","article-title":"Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan","volume":"195","author":"Lin","year":"2007","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib12","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/587992","article-title":"Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan","volume":"46","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib13","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ajg.2008.159","article-title":"Seroprevalence of chronic hepatitis B virus infection among Taiwanese human immunodeficiency virus type 1\u2013positive persons in the era of nationwide hepatitis B vaccination","volume":"104","author":"Sun","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"9814","key":"10.1016\/j.jmii.2024.11.003_bib14","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S0140-6736(11)60786-1","article-title":"Effects of education on harm-reduction programmes","volume":"379","author":"Lyu","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001625","article-title":"Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts","volume":"11","author":"Huang","year":"2014","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.jmii.2024.11.003_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jfma.2012.10.018","article-title":"The emerging HIV epidemic among men who have sex with men in Taiwan","volume":"112","author":"Huang","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2024.11.003_bib17","unstructured":"Taiwan Centers for Disease Control. Notifiable disease surveillance systems. https:\/\/nidss.cdc.gov.tw\/en\/.04\/30\/2024."},{"issue":"9","key":"10.1016\/j.jmii.2024.11.003_bib18","first-page":"517","article-title":"Taiwan's first case of perinatal transmission of HIV confirmed by a modified western blot test","volume":"6","author":"Ko","year":"1990","journal-title":"Kaohsiung J Med Sci"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jfma.2019.05.001","article-title":"Mother-to-child transmission of HIV: an 11-year experience in a single center and HIV prevention effectiveness in Taiwan","volume":"118","author":"Huang","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"22","key":"10.1016\/j.jmii.2024.11.003_bib20","first-page":"310","article-title":"The strategy for the elimination of mother-to-child transmission of HIV in taiwan, 2005\u20132019","volume":"38","author":"Su","year":"2022","journal-title":"Taiwan Epidemiology Bulletin"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(20)30040-0","article-title":"GBD 2017 and HIV estimates for Taiwan","volume":"7","author":"Lo","year":"2020","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jfma.2021.05.030","article-title":"Estimating HIV incidence, prevalence, and percent of undiagnosed infections in Taiwan using CD4 data","volume":"121","author":"Wu","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2024.11.003_bib23","series-title":"Taiwan AIDS Society Annual Meeting 2024","article-title":"HIV\/AIDS epidemiology and prevention in Taiwan","year":"2024"},{"issue":"6","key":"10.1016\/j.jmii.2024.11.003_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179870","article-title":"Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40121-022-00619-7","article-title":"Late cART initiation consistently driven by late HIV presentation: a multicenter retrospective cohort study in taiwan from 2009 to 2019","volume":"11","author":"Lee","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.jmii.2024.11.003_bib26","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jmii.2019.03.008","article-title":"Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan","volume":"53","author":"Liu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0929-6646(11)60046-6","article-title":"Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: role of socio-behavioral factors and medical encounters","volume":"110","author":"Lo","year":"2011","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amepre.2021.07.010","article-title":"Routine HIV testing and outcomes: a population-based cohort study in Taiwan","volume":"62","author":"Chen","year":"2022","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jmii.2023.11.004","article-title":"Early HIV diagnosis enhances quality-adjusted life expectancy of men who have sex with men living with HIV: a population-based cohort study in Taiwan","volume":"57","author":"Lo","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jfma.2021.03.015","article-title":"Non-opioid recreational drug use and a prolonged HIV outbreak among men who have sex with men in Taiwan: an incident case-control study, 2006\u20132015","volume":"121","author":"Lee","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"10.1016\/j.jmii.2024.11.003_bib31","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1016\/S2352-3018(22)00124-2","article-title":"HIV, chemsex, and the need for harm-reduction interventions to support gay, bisexual, and other men who have sex with men","volume":"9","author":"Strong","year":"2022","journal-title":"Lancet HIV"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26188","article-title":"Transition of a community\u2010 and person\u2010centred design for providing healthcare services to gay and bisexual men and other men who have sex with men who engage in chemsex from a facility\u2010based setting to a community\u2010led setting in Taiwan","volume":"26","author":"Strong","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jmii.2024.11.003_bib33","series-title":"The First Phase Plan to Eliminate HIV\/AIDS by 2023","year":"2021"},{"issue":"9","key":"10.1016\/j.jmii.2024.11.003_bib34","article-title":"Understanding and comparing HIV-related law and policy environments: cross-national data and accountability for the global AIDS response","volume":"5","author":"Kavanagh","year":"2020","journal-title":"BMJ Glob Heal"},{"issue":"2\u20133","key":"10.1016\/j.jmii.2024.11.003_bib35","first-page":"145","article-title":"Fear of disconnecting: global health imaginations and the transformations of the Taiwanese state","volume":"15","author":"Tseng","year":"2020","journal-title":"N Glob Stud"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7883\/yoken.JJID.2006.311","article-title":"Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy","volume":"59","author":"Sun","year":"2006","journal-title":"Jpn J Infect Dis"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1360-0443.2011.03443.x","article-title":"Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan","volume":"106","author":"Huang","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib38","first-page":"1","article-title":"The \u201cHIV Case Management Program\u201d in Taiwan: a discussion based on experience with HIV case management in the United States","volume":"29","author":"Chiu","year":"2010","journal-title":"Chin J Publ Health"},{"issue":"16","key":"10.1016\/j.jmii.2024.11.003_bib39","first-page":"284","article-title":"The program for HIV-infected case management and behavior changes of the cases","volume":"26","author":"Chi","year":"2010","journal-title":"Taiwan Epidemiol Bull"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/apc.2014.0174","article-title":"A prospective study of interactions between a case management program and retention in care on HIV suppression in Taiwan, 2008\u20132012","volume":"29","author":"Ko","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jmii.2024.11.003_bib41","series-title":"In the Fight against HIV\/AIDS: The Arduous Implementation of Government-Funded Pre-exposure Prophylaxis Programme in Taiwan","author":"Huang","year":"2024"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25897","article-title":"Towards the first 90: impact of the national HIV self\u2010test program on case finding and factors associated with linkage to confirmatory diagnosis in Taiwan","volume":"25","author":"Huang","year":"2022","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/13548500600595327","article-title":"The fight against stigma: an overview of stigma-reduction strategies and interventions","volume":"11","author":"Heijnders","year":"2006","journal-title":"Psychol Heal Med"},{"issue":"13","key":"10.1016\/j.jmii.2024.11.003_bib44","first-page":"235","article-title":"Human immunodeficiency virus screening in Taiwan, 2004-2008","volume":"26","author":"Liu","year":"2010","journal-title":"Taiwan Epidemiol Bull"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/sextrans-2011-050354","article-title":"Maximising the potential of voluntary counselling and testing for HIV: sexually transmitted infections and HIV epidemiology in a population testing for HIV and its implications for practice","volume":"88","author":"Wu","year":"2012","journal-title":"Sex Transm Infect"},{"issue":"7","key":"10.1016\/j.jmii.2024.11.003_bib46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/apc.2020.0044","article-title":"Cascade analysis of anonymous voluntary HIV counseling and testing among patients with HIV infection in Taiwan","volume":"34","author":"Lee","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"9","key":"10.1016\/j.jmii.2024.11.003_bib47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/09540121.2012.749338","article-title":"HIV risk profiles differed by gender and experience of men who had sex with men among attendees of anonymous voluntary counseling and testing in Taiwan","volume":"25","author":"Tseng","year":"2013","journal-title":"AIDS Care"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib48","doi-asserted-by":"crossref","DOI":"10.2196\/25031","article-title":"Effective Recruitment of high-risk men who have sex with men for mobile HIV testing through social networking platforms","volume":"23","author":"Chiou","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.jmii.2024.11.003_bib49","first-page":"1","article-title":"Barriers and facilitators for optimizing HIV screening target trans women in Taiwan: convergent mixed-method design","author":"Chiou","year":"2024","journal-title":"Int J Transgender Heal"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib50","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1186\/s12889-018-5500-z","article-title":"AIDS incidence trends at presentation and during follow-up among HIV-at-risk populations: a 15-year nationwide cohort study in Taiwan","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Public Heal"},{"issue":"22","key":"10.1016\/j.jmii.2024.11.003_bib51","first-page":"321","article-title":"The past, current Situation, and future development of HIV rapid testing policy and tools in Taiwan","volume":"38","author":"Chiu","year":"2022","journal-title":"Taiwan Epidemiology Bulletin"},{"issue":"6","key":"10.1016\/j.jmii.2024.11.003_bib52","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jmii.2023.08.015","article-title":"Assessment of the performance regarding confirmatory diagnosis and initiation of antiretroviral therapy under a modified national HIV testing algorithm and pay-for-performance program in Taiwan","volume":"56","author":"Huang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/dkn002","article-title":"Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan","volume":"61","author":"Chang","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib54","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jac\/dkr601","article-title":"Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan","volume":"67","author":"Lai","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/srep35779","article-title":"Prevalence of integrase strand transfer inhibitors (INSTI) resistance mutations in Taiwan","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12879-019-4389-1","article-title":"Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan","volume":"19","author":"Weng","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2024.11.003_bib57","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.2147\/IDR.S382568","article-title":"Trend of HIV transmitted drug resistance after the introduction of single-tablet regimens in southern Taiwan","volume":"15","author":"Tsai","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib58","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/dkab361","article-title":"High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan","volume":"77","author":"Huang","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/jac\/dkae086","article-title":"Trends of pre-treatment drug resistance in antiretroviral-na\u00efve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan","volume":"79","author":"Chen","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2024.11.003_bib60","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2147\/IDR.S273704","article-title":"Prevalence of HIV-1 integrase strand transfer inhibitor resistance in treatment-na\u00efve voluntary counselling and testing clients by population Sequencing and Illumina next-generation Sequencing in Taiwan","volume":"13","author":"Tsai","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib61","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1016\/S2352-3018(23)00228-X","article-title":"HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis","volume":"10","author":"Loosli","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jmii.2024.11.003_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae185","article-title":"Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho","author":"Tschumi","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.jmii.2024.11.003_bib63","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1097\/00002030-200312050-00008","article-title":"Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy","volume":"17","author":"Hung","year":"2003","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.7883\/yoken.JJID.2006.222","article-title":"Improved survival of persons with human immunodeficiency virus type 1 infection in the era of highly active antiretroviral therapy in Taiwan","volume":"59","author":"Hung","year":"2006","journal-title":"Jpn J Infect Dis"},{"issue":"7","key":"10.1016\/j.jmii.2024.11.003_bib65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1468-1293.2008.00600.x","article-title":"Trends of mortality and causes of death among HIV\u2010infected patients in Taiwan, 1984\u20132005","volume":"9","author":"Yang","year":"2008","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkh438","article-title":"Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections","volume":"54","author":"Hung","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1469-0691.2006.01367.x","article-title":"Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti\u2010retroviral therapy","volume":"12","author":"Sun","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib68","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1086\/520681","article-title":"Risk of Recurrent Nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of Fluoroquinolone resistance","volume":"45","author":"Hung","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1471-2334-10-126","article-title":"Risk of pneumocystosis after early discontinuation of prophylaxis among HIV-infected patients receiving highly active antiretroviral therapy","volume":"10","author":"Cheng","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jac\/dkv284","article-title":"Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan","volume":"71","author":"Lai","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"S4","key":"10.1016\/j.jmii.2024.11.003_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hiv.13410","article-title":"Same\u2010day and rapid initiation of antiretroviral therapy in people living with HIV in Asia. How far have we come?","volume":"23","author":"Hung","year":"2022","journal-title":"HIV Med"},{"issue":"9","key":"10.1016\/j.jmii.2024.11.003_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033246","article-title":"Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan","volume":"9","author":"Huang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jmii.2024.11.003_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2023.12.012","article-title":"Comparable clinical outcomes with same-day versus rapid initiation of antiretroviral therapy in Taiwan","volume":"140","author":"Huang","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106631","article-title":"Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens","volume":"60","author":"Chen","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2024.11.003_bib75","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jgar.2023.10.012","article-title":"Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir\/emtricitabine\/tenofovir alafenamide","volume":"36","author":"Hsu","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jmii.2024.11.003_bib76","series-title":"Guideline on when to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV","year":"2015"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmii.2019.09.003","article-title":"Taiwan guideline on oral pre-exposure prophylaxis for HIV prevention \u2013 2018 update","volume":"53","author":"Chu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.11.003_bib78","unstructured":"Taiwan AIDS Society. Taiwan guideline on oral pre-exposure prophylaxis for HIV prevention \u2013 2018 update. http:\/\/www.aids-care.org.tw\/files\/%E7%AC%AC%E4%B8%89%E7%89%88%E8%87%BA%E7%81%A3%E6%84%9B%E6%BB%8B%E6%9A%B4%E9%9C%B2%E5%89%8D%E9%A0%90%E9%98%B2%E6%80%A7%E6%8A%95%E8%97%A5%E4%BD%BF%E7%94%A8%E6%8C%87%E5%BC%95-20231101(final3).pdf. 04\/30\/2024."},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1521\/aeap.2016.28.2.128","article-title":"Willingness to self-pay for pre-exposure prophylaxis in men who have sex with men: a national online survey in Taiwan","volume":"28","author":"Ko","year":"2016","journal-title":"AIDS Educ Prev"},{"issue":"10","key":"10.1016\/j.jmii.2024.11.003_bib80","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/09540121.2018.1481195","article-title":"Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan","volume":"30","author":"Ko","year":"2018","journal-title":"AIDS Care"},{"issue":"12","key":"10.1016\/j.jmii.2024.11.003_bib81","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/apc.2021.0146","article-title":"Health Beliefs linked to HIV pre-exposure prophylaxis Use Intention among young men who have sex with men in Taiwan","volume":"35","author":"Huang","year":"2021","journal-title":"AIDS Patient Care STDS"},{"issue":"10","key":"10.1016\/j.jmii.2024.11.003_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015142","article-title":"Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey","volume":"7","author":"Lee","year":"2017","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25733","article-title":"Imperfect adherence in real life: a prevention\u2010effective perspective on adherence to daily and event\u2010driven HIV pre\u2010exposure prophylaxis among men who have sex with men \u2013 a prospective cohort study in Taiwan","volume":"24","author":"Wu","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10461-020-02964-5","article-title":"Factors associated with Preferred pre-exposure prophylaxis dosing regimen among men who have sex with men in real-world settings: a mixed-Effect Model analysis","volume":"25","author":"Wu","year":"2021","journal-title":"AIDS Behav"},{"issue":"9","key":"10.1016\/j.jmii.2024.11.003_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26163","article-title":"Preferences for long\u2010acting pre\u2010exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey","volume":"26","author":"Hsu","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib86","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1057\/s41292-022-00273-9","article-title":"Sexual health as surplus: the marketization of PrEP in Taiwan","volume":"18","author":"Huang","year":"2023","journal-title":"BioSocieties"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib87","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2015","journal-title":"Lond J Prim Care"},{"key":"10.1016\/j.jmii.2024.11.003_bib88","series-title":"National Health Insurance Act","year":"2023"},{"key":"10.1016\/j.jmii.2024.11.003_bib89","unstructured":"AVAC. PrEPWatch. https:\/\/www.prepwatch.org\/countries\/scotland\/.04\/30\/2024."},{"key":"10.1016\/j.jmii.2024.11.003_bib90","unstructured":"National Health Service. Pre-Exposure Prophylaxis (PrEP). https:\/\/www.nhs.uk\/medicines\/pre-exposure-prophylaxis-prep\/.04\/30\/2024."},{"issue":"6","key":"10.1016\/j.jmii.2024.11.003_bib91","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and Comorbidity-free life expectancy between Insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib92","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cir626","article-title":"Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study","volume":"53","author":"Hasse","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib93","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib94","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/dkr558","article-title":"Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors","volume":"67","author":"Wu","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib95","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jmii.2019.03.006","article-title":"Estimated risk of cardiovascular disease among the HIV-positive patients aged 40 years or older in Taiwan","volume":"52","author":"Wu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib96","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmii.2019.05.011","article-title":"Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: a cross-sectional study","volume":"52","author":"Yang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2024.11.003_bib97","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijid.2019.12.029","article-title":"Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir\/cobicistat\/emtricitabine\/tenofovir alafenamide","volume":"92","author":"Kuo","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib98","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib99","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jmii.2024.01.003","article-title":"Under-utilization of statins among people with HIV who were aged 40 years or older","volume":"57","author":"Wu","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"issue":"10","key":"10.1016\/j.jmii.2024.11.003_bib100","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jfma.2020.12.008","article-title":"High prevalence of sexually transmitted coinfections among at-risk people living with HIV","volume":"120","author":"Lin","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2024.11.003_bib101","article-title":"Sexually transmitted coinfections among at-risk HIV-positive MSM: implications for optimal preemptive treatment","volume":"11","author":"Wu","year":"2024","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib102","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10147-015-0804-9","article-title":"Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus","volume":"20","author":"Cheng","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib103","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.jmii.2024.11.003_bib104","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jmii.2024.11.003_bib105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jmii.2019.10.005","article-title":"Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan","volume":"54","author":"Lin","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib106","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/liv.14059","article-title":"Impact of antiretroviral therapy containing tenofovir disoproxil fumarate on the survival of patients with HBV and HIV coinfection","volume":"39","author":"Tsai","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib107","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12072-019-09953-4","article-title":"Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection","volume":"13","author":"Huang","year":"2019","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib108","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.05125-22","article-title":"Week 96 results of switching from tenofovir disoproxil fumarate-based antiretroviral therapy to Coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide among HIV\/hepatitis B virus-Coinfected patients","volume":"11","author":"Huang","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"5\u20136","key":"10.1016\/j.jmii.2024.11.003_bib109","article-title":"Virological responses to tenofovir-alafenamide-containing antiretroviral therapy in people living with HIV co-infected with lamivudine-resistant or lamivudine-susceptible hepatitis B virus","volume":"60","author":"Huang","year":"2022","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jmii.2024.11.003_bib110","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/cid\/ciab1020","article-title":"Evolution of hepatitis B virus (HBV) serologic Markers among antiretroviral-naive young people living with human immunodeficiency virus who had Undergone neonatal HBV vaccination and initiated antiretroviral therapy","volume":"75","author":"Huang","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib111","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/liv.13721","article-title":"Serological responses to revaccination against HBV in HIV\u2010positive patients born in the era of nationwide neonatal HBV vaccination","volume":"38","author":"Huang","year":"2018","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib112","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/hiv.13268","article-title":"Major revision version 11.0 of the European AIDS clinical society guidelines 2021","volume":"23","author":"Ryom","year":"2022","journal-title":"HIV Med"},{"issue":"7","key":"10.1016\/j.jmii.2024.11.003_bib113","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/511867","article-title":"Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a Matched cohort study","volume":"44","author":"Sheng","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib114","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/cid\/ciu127","article-title":"Increasing incidence of recent hepatitis D virus infection in HIV-infected patients in an area hyperendemic for hepatitis B virus infection","volume":"58","author":"Hung","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2024.11.003_bib115","series-title":"Incidence and Outcome of HDV Infection in People with HIV in the Era of Tenofovir-Containing Therapy","author":"Huang","year":"2024"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib116","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JCM.01154-10","article-title":"Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan","volume":"49","author":"Chang","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"37","key":"10.1016\/j.jmii.2024.11.003_bib117","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.3748\/wjg.v27.i37.6277","article-title":"Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan","volume":"27","author":"Huang","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.jmii.2024.11.003_bib118","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac348","article-title":"Hepatitis C virus reinfection in people with HIV in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study","volume":"9","author":"Liu","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib119","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/22221751.2022.2081620","article-title":"Hepatitis C microelimination among people living with HIV in Taiwan","volume":"11","author":"Chen","year":"2022","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"10.1016\/j.jmii.2024.11.003_bib120","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad307","article-title":"Optimal frequency of hepatitis C virus (HCV) RNA testing for detection of acute HCV infection among at-risk people with human immunodeficiency virus: a Multicenter study","volume":"10","author":"Sun","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib121","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02437-21","article-title":"Three-stage pooled plasma hepatitis C virus RNA testing for the identification of acute HCV infections in at-risk populations","volume":"10","author":"Sun","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jmii.2024.11.003_bib122","series-title":"Nationwide HCV Elimination Program and the Status of Microelimination in People with HIV in Taiwan","author":"Chen","year":"2024"},{"issue":"Supplement_3","key":"10.1016\/j.jmii.2024.11.003_bib123","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/infdis\/jiac446","article-title":"HCV microelimination for high-risk special populations","volume":"228","author":"Huang","year":"2023","journal-title":"J Infect Dis"},{"issue":"Supplement_3","key":"10.1016\/j.jmii.2024.11.003_bib124","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1093\/infdis\/jiad016","article-title":"Policy and Strategy for hepatitis C virus elimination at the national level: experience in Taiwan","volume":"228","author":"Chien","year":"2023","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jmii.2024.11.003_bib125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0000000000000065","article-title":"Cancer incidence in a nationwide HIV\/AIDS Patient cohort in Taiwan in 1998\u20132009","volume":"65","author":"Chen","year":"2014","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.jmii.2024.11.003_bib126","article-title":"Cancer incidence and risk among HIV-infected individuals in Taiwan: Results from a follow-up study combining two nationwide Registries","volume":"14","author":"Chen","year":"2023","journal-title":"J AIDS Clin Res"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmii.2021.04.004","article-title":"Participation in cancer screening among people living with HIV at a university hospital","volume":"55","author":"Wu","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib128","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmii.2023.01.015","article-title":"Patient-reported outcomes among virally suppressed people living with HIV after switching to Co-formulated bictegravir, emtricitabine and tenofovir alafenamide","volume":"56","author":"Chen","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"issue":"12","key":"10.1016\/j.jmii.2024.11.003_bib129","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1080\/09540121.2012.672716","article-title":"Identification of psychiatric disorders among human immunodeficiency virus-infected individuals in Taiwan, a nine-year nationwide population-based study","volume":"24","author":"Chen","year":"2012","journal-title":"AIDS Care"},{"key":"10.1016\/j.jmii.2024.11.003_bib130","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/465726","article-title":"Benzodiazepines and Z-drug Use among HIV-infected patients in Taiwan: a 13-year nationwide cohort study","volume":"2015","author":"Wei","year":"2015","journal-title":"BioMed Res Int"},{"issue":"11","key":"10.1016\/j.jmii.2024.11.003_bib131","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1080\/09540121.2023.2206094","article-title":"Prevalence and the associated factors of cognitive impairment among people living with HIV in Taiwan: a cross-sectional study","volume":"35","author":"Wu","year":"2023","journal-title":"AIDS Care"},{"issue":"1","key":"10.1016\/j.jmii.2024.11.003_bib132","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/s12879-023-08761-4","article-title":"Prediction of incidence of neurological disorders in HIV-infected persons in Taiwan: a nested case\u2013control study","volume":"23","author":"Weng","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jmii.2024.11.003_bib133","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/life14030294","article-title":"Self-reported health-related quality of life and Residual symptoms among Virologically suppressed people living with HIV in the era of single-tablet regimens in Taiwan: a cross-sectional study","volume":"14","author":"Cheng","year":"2024","journal-title":"Life"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224002093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224002093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T15:41:20Z","timestamp":1738683680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118224002093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1684118224002093"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.11.003","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forty years of HIV infection and AIDS in Taiwan: Reflection on the past and looking toward the future","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}